These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25073397)

  • 1. Arylsulfatase A bound to poly(butyl cyanoacrylate) nanoparticles for enzyme replacement therapy--physicochemical evaluation.
    Mühlstein A; Gelperina S; Shipulo E; Maksimenko O; Kreuter J
    Pharmazie; 2014 Jul; 69(7):518-24. PubMed ID: 25073397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of nanoparticle-bound arylsulfatase B for enzyme replacement therapy of mucopolysaccharidosis VI.
    Mühlstein A; Gelperina S; Kreuter J
    Pharmazie; 2013 Jul; 68(7):549-54. PubMed ID: 23923636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A.
    Schuster T; Mühlstein A; Yaghootfam C; Maksimenko O; Shipulo E; Gelperina S; Kreuter J; Gieselmann V; Matzner U
    J Control Release; 2017 May; 253():1-10. PubMed ID: 28215668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
    Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J
    J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain.
    Lin Y; Pan Y; Shi Y; Huang X; Jia N; Jiang JY
    Nanotechnology; 2012 Apr; 23(16):165101. PubMed ID: 22460562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
    Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
    J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy.
    Stroobants S; Gerlach D; Matthes F; Hartmann D; Fogh J; Gieselmann V; D'Hooge R; Matzner U
    Hum Mol Genet; 2011 Jul; 20(14):2760-9. PubMed ID: 21515587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulation of water-insoluble drugs in poly(butyl cyanoacrylate) nanoparticles.
    Hekmatara T; Gelperina S; Vogel V; Yang SR; Kreuter J
    J Nanosci Nanotechnol; 2009 Aug; 9(8):5091-8. PubMed ID: 19928187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion.
    Huang CY; Chen CM; Lee YD
    Int J Pharm; 2007 Jun; 338(1-2):267-75. PubMed ID: 17368981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
    Jin X; Huang A; Ping Q; Cao F; Su Z
    Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation sterilisation of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles.
    Maksimenko O; Pavlov E; Toushov E; Molin A; Stukalov Y; Prudskova T; Feldman V; Kreuter J; Gelperina S
    Int J Pharm; 2008 May; 356(1-2):325-32. PubMed ID: 18295418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
    Rempe R; Cramer S; Hüwel S; Galla HJ
    Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and lyophilization of itraconazole loaded poly(butylcyanoacrylate) nanospheres as a drug delivery system.
    Ćurić A; Keller BL; Reul R; Möschwitzer J; Fricker G
    Eur J Pharm Sci; 2015 Oct; 78():121-31. PubMed ID: 26171880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
    He M; Zhao Z; Yin L; Tang C; Yin C
    Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model.
    Ambruosi A; Gelperina S; Khalansky A; Tanski S; Theisen A; Kreuter J
    J Microencapsul; 2006 Aug; 23(5):582-92. PubMed ID: 16980278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells.
    Evangelatov A; Skrobanska R; Mladenov N; Petkova M; Yordanov G; Pankov R
    Drug Deliv; 2016 Sep; 23(7):2235-2244. PubMed ID: 25268149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of poly (butyl) cyanoacrylate nanoparticles containing vasoactive intestinal peptide against 6-hydroxydopamine-induced neurotoxicity in vitro.
    Xu ZR; Wang WF; Liang XF; Liu ZH; Liu Y; Lin L; Zhu X
    J Mol Neurosci; 2015 Apr; 55(4):854-64. PubMed ID: 25326789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle delivery to the brain--By focused ultrasound and self-assembled nanoparticle-stabilized microbubbles.
    Åslund AKO; Berg S; Hak S; Mørch Ý; Torp SH; Sandvig A; Widerøe M; Hansen R; de Lange Davies C
    J Control Release; 2015 Dec; 220(Pt A):287-294. PubMed ID: 26518721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats.
    Ambruosi A; Yamamoto H; Kreuter J
    J Drug Target; 2005 Dec; 13(10):535-42. PubMed ID: 16390814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.